Format

Send to

Choose Destination
Gastroenterol Hepatol. 2010 May;33(5):377-81. doi: 10.1016/j.gastrohep.2010.01.010. Epub 2010 Apr 2.

[Hepatitis B reactivation in an HbsAg-negative/anti-HBc-positive patient with B-cell non-Hodgkin lymphoma receiving chemotherapy with rituximab].

[Article in Spanish]

Author information

1
Sección de Aparato Digestivo, Hospital Morales Meseguer, Murcia, España. emunozb@telefonica.net

Abstract

Reactivation of hepatitis B virus infection in patients with resolved infection is rare and is usually associated with immunosuppressive therapy. Morbidity and mortality are high. Some cases of hepatitis B reactivation associated with the use of rituximab have previously been published. We present the case of a patient with B-cell non-Hodgkin lymphoma receiving combination chemotherapy with rituximab who showed hepatitis B reactivation followed by liver failure. The most recent literature on this topic is reviewed and discussed.

PMID:
20363054
DOI:
10.1016/j.gastrohep.2010.01.010
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Ediciones Doyma, S.L.
Loading ...
Support Center